{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:32:22Z","timestamp":1791952342794,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL125940"],"award-info":[{"award-number":["HL125940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL145478"],"award-info":[{"award-number":["HL145478"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DK077662"],"award-info":[{"award-number":["T32DK077662"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010261","name":"Thoracic Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.athoracsur.2018.10.034","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T04:37:47Z","timestamp":1542947867000},"page":"1046-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States"],"prefix":"10.1016","volume":"107","author":[{"given":"Chitaru","family":"Kurihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Safaeinili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahzad","family":"Akbarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.R. Scott","family":"Budinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Bharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2018.10.034_bib1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1600-6143.2004.00505.x","article-title":"Cytomegalovirus and lung transplantation","volume":"4","author":"Zamora","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib2","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1001\/jama.1989.03420240121038","article-title":"The indirect effects of cytomegalovirus infection on the outcome of organ transplantation","volume":"261","author":"Rubin","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib4","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","article-title":"Infection in organ-transplant recipients","volume":"338","author":"Fishman","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib5","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1164\/rccm.200911-1786OC","article-title":"Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation","volume":"181","author":"Snyder","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.healun.2008.05.009","article-title":"Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation","volume":"27","author":"Valentine","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1600-6143.2004.00571.x","article-title":"Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation","volume":"4","author":"Zamora","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/TP.0b013e3181ea3955","article-title":"An international survey of cytomegalovirus management practices in lung transplantation","volume":"90","author":"Zuk","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-152-12-201006150-00003","article-title":"Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial","volume":"152","author":"Palmer","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1600-6143.2011.03837.x","article-title":"Is prevention the best treatment? CMV after lung transplantation","volume":"12","author":"Patel","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib11","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1128\/jvi.67.9.5360-5366.1993","article-title":"Lungs are a major organ site of cytomegalovirus latency and recurrence","volume":"67","author":"Balthesen","year":"1993","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.TP.0000165430.65645.4F","article-title":"Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations","volume":"80","author":"Zamora","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1399-0012.2003.00152.x","article-title":"Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir","volume":"18","author":"Palmer","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1164\/ajrccm.150.1.8025741","article-title":"A\u00a0comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation","volume":"150","author":"Duncan","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1378\/chest.116.5.1265","article-title":"Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation","volume":"116","author":"Gerbase","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1378\/chest.113.4.924","article-title":"Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin","volume":"113","author":"Gutierrez","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib17","first-page":"881","article-title":"Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients","volume":"15","author":"Soghikian","year":"1996","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00007890-199901270-00023","article-title":"Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation","volume":"67","author":"Speich","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1034\/j.1600-6143.2003.00074.x","article-title":"Combination prophylaxis with ganciclovir and cytomegalovirus (CMV) immune globulin after lung transplantation: effective CMV prevention following daclizumab induction","volume":"3","author":"Weill","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1432-2277.1999.tb01210.x","article-title":"Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients","volume":"12","author":"Wreghitt","year":"1999","journal-title":"Transpl Int"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib21","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/j.1600-6143.2008.02280.x","article-title":"Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation","volume":"8","author":"Weigt","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1053-2498(01)00360-6","article-title":"Risk factors\u00a0for bronchiolitis obliterans: a systematic review of\u00a0recent publications","volume":"21","author":"Sharples","year":"2002","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/rccm.200310-1405OC","article-title":"Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome","volume":"170","author":"Tamm","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/TP.0000000000000832","article-title":"Cytomegalovirus infection after intestinal\/multivisceral transplantation: a single-center experience with 210 cases","volume":"100","author":"Nagai","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib25","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cis818","article-title":"State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician","volume":"55","author":"Egli","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib26","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2018.10.034_bib27","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497518316862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497518316862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T03:59:03Z","timestamp":1757735943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497518316862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0003497518316862"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2018.10.034","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2018.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The Society of Thoracic Surgeons Published by Elsevier","name":"copyright","label":"Copyright"}]}}